Form 4: Centene Director Thomas Greco Acquires 17,000 Shares in Open Market Purchase

Centene director Thomas Greco purchased 17,000 shares of common stock at an average price of $59.75.

Summary

• On December 18, 2024, Thomas Greco, a director at Centene Corp, acquired 17,000 shares of common stock.
• The shares were purchased at a weighted average price of $59.75, with individual prices ranging from $59.68 to $59.76.
• Following the transaction, Mr. Greco directly owns 19,309 shares, which includes 2,309 restricted stock units subject to vesting requirements.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The purchase of shares by a director is generally seen as a positive sign, but it's a routine transaction and not a major event.

Positives

• The purchase of shares by a director can be seen as a positive sign of confidence in the company's future prospects.

Industry Context

This is a routine filing related to insider trading activity and is common for publicly traded companies. It does not indicate any specific trend in the healthcare industry.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and this filing is consistent with those requirements.
• The purchase of shares by a director is a common occurrence and does not indicate any unusual activity compared to other companies.

Stakeholder Impact

• The share purchase may have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

Centene, CNC, Director, Insider Trading, Share Purchase, Form 4, Stock Acquisition, Thomas Greco